These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 32561415)
1. Heterogeneity and vascular permeability of breast cancer brain metastases. Babak MV; Zalutsky MR; Balyasnikova IV Cancer Lett; 2020 Oct; 489():174-181. PubMed ID: 32561415 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer. Lockman PR; Mittapalli RK; Taskar KS; Rudraraju V; Gril B; Bohn KA; Adkins CE; Roberts A; Thorsheim HR; Gaasch JA; Huang S; Palmieri D; Steeg PS; Smith QR Clin Cancer Res; 2010 Dec; 16(23):5664-78. PubMed ID: 20829328 [TBL] [Abstract][Full Text] [Related]
3. Treatment strategies for breast cancer brain metastases. Bailleux C; Eberst L; Bachelot T Br J Cancer; 2021 Jan; 124(1):142-155. PubMed ID: 33250512 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal MRI evaluation of intracranial development and vascular characteristics of breast cancer brain metastases in a mouse model. Zhou H; Chen M; Zhao D PLoS One; 2013; 8(4):e62238. PubMed ID: 23638013 [TBL] [Abstract][Full Text] [Related]
5. Characterization of passive permeability at the blood-tumor barrier in five preclinical models of brain metastases of breast cancer. Adkins CE; Mohammad AS; Terrell-Hall TB; Dolan EL; Shah N; Sechrest E; Griffith J; Lockman PR Clin Exp Metastasis; 2016 Apr; 33(4):373-83. PubMed ID: 26944053 [TBL] [Abstract][Full Text] [Related]
6. Biology of breast cancer brain metastases and novel therapies targeting the blood brain barrier: an updated review. Zhao H; Wang L; Ji X; Zhang L; Li C Med Oncol; 2023 May; 40(6):181. PubMed ID: 37202575 [TBL] [Abstract][Full Text] [Related]
7. Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastases. Bernatz S; Ilina EI; Devraj K; Harter PN; Mueller K; Kleber S; Braun Y; Penski C; Renner C; Halder R; Jennewein L; Solbach C; Thorsen F; Pestalozzi BC; Mischo A; Mittelbronn M J Exp Clin Cancer Res; 2019 Oct; 38(1):434. PubMed ID: 31665089 [TBL] [Abstract][Full Text] [Related]
8. JAK2-binding long noncoding RNA promotes breast cancer brain metastasis. Wang S; Liang K; Hu Q; Li P; Song J; Yang Y; Yao J; Mangala LS; Li C; Yang W; Park PK; Hawke DH; Zhou J; Zhou Y; Xia W; Hung MC; Marks JR; Gallick GE; Lopez-Berestein G; Flores ER; Sood AK; Huang S; Yu D; Yang L; Lin C J Clin Invest; 2017 Dec; 127(12):4498-4515. PubMed ID: 29130936 [TBL] [Abstract][Full Text] [Related]
9. Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer. Lyle LT; Lockman PR; Adkins CE; Mohammad AS; Sechrest E; Hua E; Palmieri D; Liewehr DJ; Steinberg SM; Kloc W; Izycka-Swieszewska E; Duchnowska R; Nayyar N; Brastianos PK; Steeg PS; Gril B Clin Cancer Res; 2016 Nov; 22(21):5287-5299. PubMed ID: 27245829 [TBL] [Abstract][Full Text] [Related]
10. Pathogenesis and vascular integrity of breast cancer brain metastasis. Lu W; Bucana CD; Schroit AJ Int J Cancer; 2007 Mar; 120(5):1023-6. PubMed ID: 17187362 [TBL] [Abstract][Full Text] [Related]
12. SNORA71B promotes breast cancer cells across blood-brain barrier by inducing epithelial-mesenchymal transition. Duan S; Luo X; Zeng H; Zhan X; Yuan C Breast Cancer; 2020 Nov; 27(6):1072-1081. PubMed ID: 32458152 [TBL] [Abstract][Full Text] [Related]
13. Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis. Shen Q; Sahin AA; Hess KR; Suki D; Aldape KD; Sawaya R; Ibrahim NK Oncologist; 2015 May; 20(5):466-73. PubMed ID: 25802405 [TBL] [Abstract][Full Text] [Related]
14. Quantitative Fluorescence Microscopy Measures Vascular Pore Size in Primary and Metastatic Brain Tumors. Mittapalli RK; Adkins CE; Bohn KA; Mohammad AS; Lockman JA; Lockman PR Cancer Res; 2017 Jan; 77(2):238-246. PubMed ID: 27815391 [TBL] [Abstract][Full Text] [Related]
15. The structure of blood-tumor barrier and distribution of chemotherapeutic drugs in non-small cell lung cancer brain metastases. Ye LY; Sun LX; Zhong XH; Chen XS; Hu S; Xu RR; Zeng XN; Xie WP; Kong H Cancer Cell Int; 2021 Oct; 21(1):556. PubMed ID: 34689774 [TBL] [Abstract][Full Text] [Related]
16. PSMA-targeted nanoparticles for specific penetration of blood-brain tumor barrier and combined therapy of brain metastases. Ni J; Miao T; Su M; Khan NU; Ju X; Chen H; Liu F; Han L J Control Release; 2021 Jan; 329():934-947. PubMed ID: 33069744 [TBL] [Abstract][Full Text] [Related]
17. Impact of Blood-Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases. Osswald M; Blaes J; Liao Y; Solecki G; Gömmel M; Berghoff AS; Salphati L; Wallin JJ; Phillips HS; Wick W; Winkler F Clin Cancer Res; 2016 Dec; 22(24):6078-6087. PubMed ID: 27521448 [TBL] [Abstract][Full Text] [Related]
18. Therapeutics for Brain Metastases, v3. Steeg PS; Zimmer A; Gril B Clin Cancer Res; 2016 Dec; 22(24):5953-5955. PubMed ID: 27803066 [TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblast promote transmigration through endothelial brain cells in three-dimensional in vitro models. Choi YP; Lee JH; Gao MQ; Kim BG; Kang S; Kim SH; Cho NH Int J Cancer; 2014 Nov; 135(9):2024-33. PubMed ID: 24643985 [TBL] [Abstract][Full Text] [Related]
20. Calcium-dependent potassium channels as a target protein for modulation of the blood-brain tumor barrier. Ningaraj NS; Rao M; Black KL Drug News Perspect; 2003 Jun; 16(5):291-8. PubMed ID: 12942160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]